Fractures, osteoporosis and falls. Injury, Occupational Diseases, Poisoning Fracture
Conditions
Interventions
Current interventions as of 11/11/2009:
500,000 IU cholecalciferol or placebo
Previous interventions:
500,000 IU ergocalciferol or placebo annually
Sponsors
The University of Melbourne (Australia)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female 2. Over 70 years old 3. High risk of falls or fracture
Exclusion criteria
Exclusion criteria: 1. Hypercalcemia 2. Bone-trophic medications 3. Renal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of fracture rate in active arm compared to placebo. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Reduction in rate of falls 2. Improvement in mental well-being 3. Duration of independent residency 4. Reduction in total healthcare utilisation (added 11/11/2009) Substudy group are tested for various parameters of muscle strength, balance, gait and mobility. | — |
Countries
Australia
Outcome results
None listed